| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/06/1995 | WO1995008983A1 Oral delivery composition forming a microemulsion |
| 04/06/1995 | WO1995008982A1 Uv protective film-forming composition |
| 04/06/1995 | WO1995008981A1 Contraceptive compositions |
| 04/06/1995 | WO1995008931A1 Composition and system for oral administration to animals |
| 04/06/1995 | WO1995008920A1 Substantive antimicrobial phosphates |
| 04/06/1995 | WO1995007072A3 Active principles and gas containing microparticles |
| 04/06/1995 | WO1994028895A3 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 04/06/1995 | DE4333561A1 Gel body |
| 04/06/1995 | CA2173101A1 Contraceptive compositions |
| 04/06/1995 | CA2172997A1 Insulin-secreting cell lines, methods of production and use |
| 04/06/1995 | CA2172978A1 Arteriosclerosis remedy |
| 04/06/1995 | CA2172601A1 Perfluorocarbons as anti-inflammatory agents |
| 04/06/1995 | CA2172393A1 Methods of stimulating phagocytosis |
| 04/06/1995 | CA2172066A1 Composition and system for oral administration to animals |
| 04/06/1995 | CA2168846A1 Ranitidine and calcium carbonate pharmaceutical combination product |
| 04/06/1995 | CA2167526A1 Monoglyceride/lactate ester permeation enhancer |
| 04/06/1995 | CA2165802A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin |
| 04/06/1995 | CA2133614A1 Retinol containing anhydrous and stable cosmetic or pharmaceutical composition for skin and use thereof for the treatment of skin diseases |
| 04/05/1995 | EP0646650A2 New spheroidal crystal sugar and method of manufacuture |
| 04/05/1995 | EP0646379A1 Insulin formulation |
| 04/05/1995 | EP0646374A1 Double-coated oxcarbazepine containing tablets |
| 04/05/1995 | EP0646372A1 Medicine containing capsaicin for the treatment of chronic rhinopathy |
| 04/05/1995 | EP0646371A1 Anhydrous cosmetic or pharmaceutical composition containing retinol |
| 04/05/1995 | EP0646368A1 A gel-resembling composition containing organopolysiloxane, without a gelling agent used in cosmetic and dermatology |
| 04/05/1995 | EP0646367A2 Improved method for manufacturing freeze dried dosages in a multilaminate blister pack |
| 04/05/1995 | EP0646178A1 expression cassette with regularoty regions functional in the mammmlian host |
| 04/05/1995 | EP0646022A1 Prosthetic devices having enhanced osteogenic properties |
| 04/05/1995 | EP0646012A1 Wound healing and treatment of fibrotic disorders |
| 04/05/1995 | EP0646003A1 Preparation and use of novel cyclodextrin-based dispersible colloidal systems in the form of nanospheres. |
| 04/05/1995 | EP0646002A1 Preparation and use of novel cyclodextrin-based dispersible nanovesicular colloidal systems in the form of nanocapsules. |
| 04/05/1995 | EP0646000A1 Compositions using microencapsulated neutralizing antibodies |
| 04/05/1995 | EP0645997A1 Cosmetic containing phospholipids and fluorocarbon compounds. |
| 04/05/1995 | EP0469082B1 Liposomal targeting of ischemic tissue |
| 04/05/1995 | EP0464163B1 Use of supercritical fluids to obtain porous sponges of biodegradable polymers |
| 04/05/1995 | CN1100949A "Jinying" health-care series product and preparation method thereof |
| 04/05/1995 | CN1100947A Traditional Chinese medicinal injection which can effect a radical cure of arthritis and production method thereof |
| 04/05/1995 | CN1100946A Injection for curing anal fissure |
| 04/05/1995 | CN1100942A Health-care capsule for male |
| 04/05/1995 | CN1100936A Life-prolonging and anti-tumor preparation of Chinese traditional medicine and preparation method |
| 04/05/1995 | CN1100929A Gas-forming capsule for gastrointestinal double contrast radiography |
| 04/05/1995 | CN1028071C Method for preparation of medical medicinal chewing gum |
| 04/05/1995 | CA2133513A1 Gel like organopolysiloxane composition without gelling agent, useful in cosmetic and dermatological applications |
| 04/05/1995 | CA2107649A1 T and f hemostatic |
| 04/04/1995 | US5403951 Crystalline modification of 2-dimethylaminoethyl-n-butylaminobenzoate hydrochloride, method for production thereof and pharmaceutical preparation for anaesthesia of eyes, based thereon |
| 04/04/1995 | US5403922 Surfactants, vesicular agents |
| 04/04/1995 | US5403893 Interpenetrating-polymer network phase-transition gels |
| 04/04/1995 | US5403858 Perfusion solution ethanol free; antitumor agents |
| 04/04/1995 | US5403841 Administrable as drops that gel upon installation in the eye |
| 04/04/1995 | US5403727 Allowing galactosidase to act on solution of lactoneotrehalose |
| 04/04/1995 | US5403598 Charging pressure reactor containing tear mixture with carbon dioxide and mixing to equilibrate and maintain bicarbonate |
| 04/04/1995 | US5403595 Contains physical constraint modulation system contining microparticle of lobaline in a biodegradable polymer to release effective amount of lobaline to diminish indivisuals desire for nicotine for a period of time |
| 04/04/1995 | US5403594 Oral spiramycin formulations and method for preparing same |
| 04/04/1995 | US5403593 Melt granulated compositions for preparing sustained release dosage forms |
| 04/04/1995 | US5403590 Method of pulsatile drug infusion |
| 04/04/1995 | US5403575 Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them |
| 04/04/1995 | CA1335076C Pharmaceutical composition and method for intranasal administration |
| 04/02/1995 | CA2133056A1 Fully water-dilutable microemulsions |
| 03/31/1995 | CA2133180A1 Rapamycin formulation for iv injection |
| 03/31/1995 | CA2133179A1 Rapamycin formulation for iv injection |
| 03/31/1995 | CA2133174A1 Rapamycin formulations for oral administration |
| 03/30/1995 | WO1995008565A1 Use of angiotensin ii analogs in tissue repair |
| 03/30/1995 | WO1995008562A1 Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition |
| 03/30/1995 | WO1995008355A1 Methods for enhancing vascularization of implant devices |
| 03/30/1995 | WO1995008349A1 COMPOSITION CONTAINING OMEGA 3 AND/OR OMEGA 6 POLYUNSATURATED ACIDS HAVING FROM 12 to 22 CARBON ATOMS |
| 03/30/1995 | WO1995008337A1 Use of angiotensin iii and analogs thereof in tissue repair |
| 03/30/1995 | WO1995008331A1 Enteric coated oral compositions containing bisphosphonic acid derivatives |
| 03/30/1995 | WO1995008330A1 Transdermal therapeutic system with acetylsalicylic acid as active substance |
| 03/30/1995 | WO1995008325A1 Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease |
| 03/30/1995 | WO1995008324A1 Volatile active substance containing plaster that may be produced without solvents |
| 03/30/1995 | WO1995008323A1 Budesonide pellets with a controlled release pattern and process for producing them |
| 03/30/1995 | WO1995008322A1 Method of encapsulation and microcapsules produced thereby |
| 03/30/1995 | WO1995008321A1 A capsule for delivering drugs into cattle stomachs |
| 03/30/1995 | WO1995008320A1 Hydrophobic polymeric microparticles |
| 03/30/1995 | WO1995005452A3 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
| 03/30/1995 | WO1994026113A3 Pour-on formulations containinng polymeric material, glycols and glycerides |
| 03/30/1995 | CA2172605A1 Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease |
| 03/30/1995 | CA2172494A1 Use of angiotensin ii analogs in tissue repair |
| 03/30/1995 | CA2172040A1 Hydrophobic polymeric microparticles |
| 03/30/1995 | CA2171607A1 Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition |
| 03/30/1995 | CA2148354A1 Methods for enhancing vascularization of implant devices |
| 03/29/1995 | EP0645145A2 Stabilized pharmaceutical composition and stabilizing solvent |
| 03/29/1995 | EP0645140A1 Compositions for rectal administration containing benzimidazoles and fatty acid salts |
| 03/29/1995 | EP0645138A2 Pharmaceutical composition for maintaining and/or reestablishing a rate of blood platelet aggregation clone to the normal value |
| 03/29/1995 | EP0645136A2 Physiologically active substance-prolonged releasing-type pharmaceutical preparation |
| 03/29/1995 | EP0645096A1 Powdered mannitol of reduced friability and its preparation |
| 03/29/1995 | EP0645048A1 Preparation of controlled size inorganic particles for use in separations, as magnetic molecular switches, and as inorganic liposomes for medical applications |
| 03/29/1995 | EP0644929A1 System and method for transplantation of cells |
| 03/29/1995 | EP0644785A1 Arrangement and method for dispensing preservative-free nasal sprays and similar preparations |
| 03/29/1995 | EP0644777A1 Microparticles, method of producing them and their use for diagnostic purposes |
| 03/29/1995 | EP0644776A1 Use of microcapsules as contrasting agents in colour doppler sonography |
| 03/29/1995 | EP0644771A1 Erythropoietin drug delivery system |
| 03/29/1995 | EP0644770A1 Stabilized somatotropin for parenteral administration |
| 03/29/1995 | EP0644756A1 System for controlled release of antiarrhythmic agents |
| 03/29/1995 | EP0644753A1 Burn foam and delivery system |
| 03/29/1995 | EP0644746A1 The use of glycerin in moderating transdermal drug delivery |
| 03/29/1995 | EP0644719A1 Water-soluble, instant tea product |
| 03/29/1995 | EP0644716A1 Medical uses of trioxolane and diperoxide compounds |
| 03/29/1995 | EP0483370B1 Percutaneous preparation containing estradiol |
| 03/29/1995 | CN1100655A Compound medicine containg buffer and thrombase |
| 03/29/1995 | CN1100653A Yinhuang tablet and method for preparing same |